Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Redskins’ Cedric Griffin Banned Four Games for Failing Drug Test

Don't Miss Out —
Follow us on:

Dec. 4 (Bloomberg) -- Washington Redskins cornerback Cedric Griffin was suspended without pay for four games after violating the National Football League’s performance-enhancing drug policy.

Griffin, 30, will be eligible to return to the team’s active roster on Dec. 31, the day after the Redskins’ regular-season finale against the Dallas Cowboys, the NFL said in an e-mailed statement. The specific drug he tested positive for wasn’t disclosed.

Griffin, who started one of nine games he played in this season, had 33 total tackles and one forced fumble. He was selected in the second round of the 2006 NFL draft by Minnesota and started for the Vikings from 2007-2011. He joined Washington as a free agent during the off season.

Washington is 6-6 this season, tied with the Cowboys and one game behind the New York Giants (7-5) in the National Football Conference’s East Division.

To contact the reporter on this story: Mason Levinson in New York at mlevinson@bloomberg.net

To contact the editor responsible for this story: Michael Sillup at msillup@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.